Amylyx制药公司宣布,其针对AMX0035的2期开放标签Helios试验数据,已在权威医学期刊《临床研究杂志》上经同行评审后正式发表。
Amylyx制药公司宣布,其针对AMX0035的2期开放标签Helios试验数据,已在权威医学期刊《临床研究杂志》上经同行评审后正式发表。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.